These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38716991)

  • 1. Cost-Effectiveness Related to Implantable Electronic Cardiac Devices: An Ever-Constant Concern.
    Camanho LEM
    Arq Bras Cardiol; 2024 Apr; 121(4):e20240185. PubMed ID: 38716991
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac Pacing and Defibrillation Devices: Cost and Effectiveness.
    Groeneveld PW; Dixit S
    Annu Rev Med; 2017 Jan; 68():1-13. PubMed ID: 27686020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technology under the skin].
    Wester K
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3255. PubMed ID: 9772810
    [No Abstract]   [Full Text] [Related]  

  • 4. [Implantable pacemaker-cardioverter-defibrillator. A cost-effective and life-prolonging treatment].
    Ohm OJ
    Tidsskr Nor Laegeforen; 1997 Apr; 117(9):1263-5. PubMed ID: 9182350
    [No Abstract]   [Full Text] [Related]  

  • 5. Yes to cardiac devices. But at what cost?
    Leyva F
    Europace; 2013 Mar; 15(3):313-4. PubMed ID: 23243130
    [No Abstract]   [Full Text] [Related]  

  • 6. Funding for cardiac pacing and defibrillators in Calgary: the Robin Hood philosophy.
    Wyse DG; Gillis AM
    Pacing Clin Electrophysiol; 1993 Dec; 16(12):2305-9. PubMed ID: 7508608
    [No Abstract]   [Full Text] [Related]  

  • 7. The cost-effectiveness of cardiovascular medicine in Greece: brief notes.
    Vardas PE
    Hellenic J Cardiol; 2012; 53(4):333-4. PubMed ID: 22796825
    [No Abstract]   [Full Text] [Related]  

  • 8. Health economic concerns on cardiac rhythm management devices longevity and how to overcome them.
    Capucci A; Luzi M; Cipolletta L; Molini S
    Expert Rev Med Devices; 2016; 13(3):297-303. PubMed ID: 26778415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing mortality in patients with advanced cardiovascular disease: subgroups, subgroups and more subgroups..
    Saksena S
    J Interv Card Electrophysiol; 2004 Feb; 10(1):7-8. PubMed ID: 15049332
    [No Abstract]   [Full Text] [Related]  

  • 10. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(7):1-199. PubMed ID: 30443279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-to-heart partnerships cut costs of cardiac products.
    Doyle FF; Donahue RE
    Mater Manag Health Care; 1997 Apr; 6(4):18, 20. PubMed ID: 10166585
    [No Abstract]   [Full Text] [Related]  

  • 12. [Update on current care guidelines. Current care guideline: cardiac pacemaker therapy].
    Duodecim; 2010; 126(4):391-2. PubMed ID: 20486489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden death prevention with implantable devices.
    Passman R; Kadish A
    Circulation; 2007 Jul; 116(5):561-71. PubMed ID: 17664385
    [No Abstract]   [Full Text] [Related]  

  • 14. Statistics on the use of cardiac electronic devices and electrophysiological procedures in 55 ESC countries: 2013 report from the European Heart Rhythm Association (EHRA).
    Arribas F; Auricchio A; Boriani G; Brugada J; Deharo JC; Hindriks G; Kuck KH; Merino JL; Vardas P; Wolpert C; Zeppenfeld K
    Europace; 2014 Apr; 16 Suppl 1():i1-78. PubMed ID: 24755466
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost efficiency and reimbursement of remote monitoring: a US perspective.
    Slotwiner D; Wilkoff B
    Europace; 2013 Jun; 15 Suppl 1():i54-i58. PubMed ID: 23737232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Remote monitoring of implantable cardiac devices: health technology assessment ].
    Ricci RP; Locati ET; Campana A; Cavallaro C; Giammaria M; Landolina M; Marzegalli M; Melissano D
    G Ital Cardiol (Rome); 2015 May; 16(5):295-303. PubMed ID: 25994466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote monitoring of cardiac implantable devices in the Asia-Pacific.
    Lau CP; Zhang S
    Europace; 2013 Jun; 15 Suppl 1():i65-i68. PubMed ID: 23737235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac pacing and defibrillation in developing nations.
    Oto A
    Pacing Clin Electrophysiol; 1995 May; 18(5 Pt 1):1063-4. PubMed ID: 7659559
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-of-illness study of patients subjected to cardiac rhythm management devices implantation: results from a single tertiary centre.
    Fanourgiakis J; Simantirakis E; Maniadakis N; Kourlaba G; Kanoupakis E; Chrysostomakis S; Vardas P
    Europace; 2013 Mar; 15(3):366-75. PubMed ID: 23148117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Telemonitoring of implantable devices. Practical aspects and ongoing studies].
    Bosch RF; Krause-Allmendinger H; Villena P; Kruck I
    Herzschrittmacherther Elektrophysiol; 2009 Dec; 20(4):179-84. PubMed ID: 19941146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.